“Carpal%2Btunnel%2Bsyndrome”的搜索结果，显示 141-150 项，共有 7964 项

1. 神经科- 临床试验- 妙佑医疗国际

   A Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease ... (2) early onset non-Alzheimer's Disease (EO-nonAD) ...

2. 神经科- 临床试验- 妙佑医疗国际

   Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study ...

4. 肺癌计划- 临床试验- 妙佑医疗国际

   ... 2B (Dose Expansion) with Cohort D1 (monotherapy SAR444881). A Study to Collect Thoracic Specimens to Develop a Thoracic Specimen Registry. Rochester, Minn ...

5. 神经科- 临床试验- 妙佑医疗国际

   Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization ...

6. 普通内科- 临床试验- 妙佑医疗国际

   The primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with short bowel syndrome (SBS). ... Go to page 22.

7. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

8. 妙佑医疗国际 - 治疗糖尿病：2 型糖尿病的用药

   生活方式的选择，包括健康饮食、运动和保持健康体重，是控制2 型糖尿病的关键所在。但是，您也可能需要服用药物将血糖（也称为葡萄糖）维持在健康水平。

9. 神经科- 临床试验- 妙佑医疗国际

   ... Disease (EOAD) participants, (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial. A Study ...